Regen BioPharma Inc
(OTCPK:RGBP)
$
0.28
0.07459 (36.31%)
Market Cap: 1.26 Mil
Enterprise Value: 1.58 Mil
PE Ratio: 0
PB Ratio: 0
GF Score: 35/100 Regen BioPharma Inc At Emerging Growth Conference Transcript
Jan 25, 2023 / 08:30PM GMT
Release Date Price:
$7.12
(-1.04%)
Ana Berry
Berry Media, Inc. - Moderator
Welcome back, everyone. Next up, we have Regen BioPharma Inc. It trades on the OTC pink sheets under the symbol RGBP and RGBPP. And as a publicly traded biotechnology company focused on the immunology and immunotherapy space, rapidly advancing novel technologies through preclinical and Phase 1 and 2 clinical trials and small molecule therapies for treating cancer and autoimmune disorders. Please welcome the President and CEO, David Koos, as well as Senior Scientific Consultant, Harry Lander. Welcome back, gentlemen.
David Koos
Regen BioPharma, Inc. - CEO & Chairman
Hello, good morning. I guess it's good afternoon back there.
Ana Berry
Berry Media, Inc. - Moderator
People are all over the world
David Koos
Regen BioPharma, Inc. - CEO & Chairman
Yes.
Ana Berry;David Koos
Berry Media, Inc. - Moderator;Regen
So you can get all three if you need.
Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot